Having IP that supports addressing development of new materials for regenerative medicine, drug delivery and 3D manufacturing, 21MedTech is a medical technologies company offering new, highly advanced biomedical materials. The firm's commitment is to provide solutions to surgeons, physicians and healthcare providers that ensure optimal outcomes for patients. Areas of expertise in the arenas of materials synthesis, fabrication, and 3D printing havethe potential to transform medical therapies in orthopaedics, cardiology, urology gynecology, pain management, anti-infective therapies and other drug delivery applications. Principals of the ftm work with pharmaceutical, medical devices and 3D technology companies to provide the expertise and materials that will enable them to transform their markets.